Literature DB >> 21153419

Cobalamin C defect presenting as severe neonatal hyperammonemia.

Diego Martinelli1, Andrea Dotta, Laura Massella, Stefano Picca, Alessandra Di Pede, Sara Boenzi, Chiara Aiello, Carlo Dionisi-Vici.   

Abstract

UNLABELLED: Cobalamin C (Cbl-C) defect is the most common inborn error of cobalamin metabolism which causes a block in the pathway responsible for the synthesis of its two metabolically active forms methyl- and adenosylcobalamin. Cbl-C defect causes the accumulation of methylmalonic acid and homocysteine and decreased methionine synthesis. The clinical presentation of patients with early-onset Cbl-C defect, characterized by a multisystem disease with severe neurological, ocular, hematological, renal, gastrointestinal, cardiac, and pulmonary manifestations, differs considerably from what observed in the "classical" form of methylmalonic aciduria caused by defect of methylmalonyl-CoA mutase. This last condition is in most cases dominated in the neonatal period by a metabolic encephalopathy "intoxication type" with severe hyperammonemia and ketoacidosis. We report a Cbl-C defect patient presenting a neonatal encephalopathy with severe hyperammonemia and ketoacidosis who was successfully treated with peritoneal dialysis.
CONCLUSION: To the best of our knowledge, there are no reported cases of Cbl-C defect showing an acute presentation resembling a classical methylmalonic aciduria. This observation enlarges the spectrum of inherited diseases to be considered in the differential diagnosis of neonatal hyperammonemia.

Entities:  

Mesh:

Year:  2010        PMID: 21153419     DOI: 10.1007/s00431-010-1371-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Cobalamin C defect associated with hemolytic-uremic syndrome.

Authors:  M T Geraghty; E J Perlman; L S Martin; S J Hayflick; J F Casella; D S Rosenblatt; D Valle
Journal:  J Pediatr       Date:  1992-06       Impact factor: 4.406

Review 2.  Medical management and dialysis therapy for the infant with an inborn error of metabolism.

Authors:  Stefano Picca; Andrea Bartuli; Carlo Dionisi-Vici
Journal:  Semin Nephrol       Date:  2008-09       Impact factor: 5.299

Review 3.  Methylmalonic and propionic aciduria.

Authors:  Federica Deodato; Sara Boenzi; Filippo M Santorelli; Carlo Dionisi-Vici
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

4.  Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type.

Authors:  Jordan P Lerner-Ellis; Jamie C Tirone; Peter D Pawelek; Carole Doré; Janet L Atkinson; David Watkins; Chantal F Morel; T Mary Fujiwara; Emily Moras; Angela R Hosack; Gail V Dunbar; Hana Antonicka; Vince Forgetta; C Melissa Dobson; Daniel Leclerc; Roy A Gravel; Eric A Shoubridge; James W Coulton; Pierre Lepage; Johanna M Rommens; Kenneth Morgan; David S Rosenblatt
Journal:  Nat Genet       Date:  2005-11-27       Impact factor: 38.330

5.  N-carbamylglutamate protects patients with decompensated propionic aciduria from hyperammonaemia.

Authors:  B Gebhardt; S Dittrich; S Parbel; S Vlaho; O Matsika; H Bohles
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 6.  Cobalamin C defect: natural history, pathophysiology, and treatment.

Authors:  Diego Martinelli; Federica Deodato; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2010-07-15       Impact factor: 4.982

7.  Potential for misdiagnosis due to lack of metabolic derangement in combined methylmalonic aciduria/hyperhomocysteinemia (cblC) in the neonate.

Authors:  Cary O Harding; De-Ann M Pillers; Robert D Steiner; Teodoro Bottiglieri; David S Rosenblatt; Jason Debley; K Michael Gibson
Journal:  J Perinatol       Date:  2003 Jul-Aug       Impact factor: 2.521

8.  Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?

Authors:  Virginie Levrat; Isabelle Forest; Alain Fouilhoux; Cécile Acquaviva; Christine Vianey-Saban; Nathalie Guffon
Journal:  Orphanet J Rare Dis       Date:  2008-01-30       Impact factor: 4.123

Review 9.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

Review 10.  Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.

Authors:  S Kölker; S W Sauer; G F Hoffmann; I Müller; M A Morath; J G Okun
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

View more
  8 in total

1.  Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria.

Authors:  Francesca Menni; Sara Testa; Sophie Guez; Gabriella Chiarelli; Luisella Alberti; Susanna Esposito
Journal:  Pediatr Nephrol       Date:  2012-03-25       Impact factor: 3.714

Review 2.  Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.

Authors:  Marina A Morath; Friederike Hörster; Sven W Sauer
Journal:  Pediatr Nephrol       Date:  2012-07-20       Impact factor: 3.714

3.  The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans.

Authors:  Marianna Caterino; Anna Pastore; Maria Grazia Strozziero; Gianna Di Giovamberardino; Esther Imperlini; Emanuela Scolamiero; Laura Ingenito; Sara Boenzi; Ferdinando Ceravolo; Diego Martinelli; Carlo Dionisi-Vici; Margherita Ruoppolo
Journal:  J Inherit Metab Dis       Date:  2015-01-14       Impact factor: 4.982

Review 4.  Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.

Authors:  Nuria Carrillo-Carrasco; Randy J Chandler; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

5.  The vitamin B12 processing enzyme, mmachc, is essential for zebrafish survival, growth and retinal morphology.

Authors:  Jennifer L Sloan; Nathan P Achilly; Madeline L Arnold; Jerrel L Catlett; Trevor Blake; Kevin Bishop; Marypat Jones; Ursula Harper; Milton A English; Stacie Anderson; Niraj S Trivedi; Abdel Elkahloun; Victoria Hoffmann; Brian P Brooks; Raman Sood; Charles P Venditti
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

6.  Clinical presentation and outcome in a series of 88 patients with the cblC defect.

Authors:  Sabine Fischer; Martina Huemer; Matthias Baumgartner; Federica Deodato; Diana Ballhausen; Avihu Boneh; Alberto B Burlina; Roberto Cerone; Paula Garcia; Gülden Gökçay; Stephanie Grünewald; Johannes Häberle; Jaak Jaeken; David Ketteridge; Martin Lindner; Hanna Mandel; Diego Martinelli; Esmeralda G Martins; Karl O Schwab; Sarah C Gruenert; Bernd C Schwahn; László Sztriha; Maren Tomaske; Friedrich Trefz; Laura Vilarinho; David S Rosenblatt; Brian Fowler; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2014-03-06       Impact factor: 4.982

7.  A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency.

Authors:  Irini Manoli; Jennifer G Myles; Jennifer L Sloan; Nuria Carrillo-Carrasco; Eva Morava; Kevin A Strauss; Holmes Morton; Charles P Venditti
Journal:  Genet Med       Date:  2015-08-13       Impact factor: 8.822

8.  Clinical, phenotypic and genetic landscape of case reports with genetically proven inherited disorders of vitamin B12 metabolism: A meta-analysis.

Authors:  Arnaud Wiedemann; Abderrahim Oussalah; Nathalie Lamireau; Maurane Théron; Melissa Julien; Jean-Philippe Mergnac; Baptiste Augay; Pauline Deniaud; Tom Alix; Marine Frayssinoux; François Feillet; Jean-Louis Guéant
Journal:  Cell Rep Med       Date:  2022-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.